Guoping Ren
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 17
- Prostate Cancer Diagnosis and Treatment 6
- Lung Cancer Treatments and Mutations 4
-
- Cancer-related gene regulation 4
- Ubiquitin and proteasome pathways 3
- Co-authors
- Yong‐Jie Lu (6 shared papers)Xueying Mao (6 shared papers)Daniel M. Berney (6 shared papers)Elzbieta Stankiewicz (5 shared papers)Jili Wang (8 shared papers)Luis Beltrán (3 shared papers)Jimin Shao (3 shared papers)Xiaoyan Liu (8 shared papers)
- Journals
- BMC Cancer (2 papers)Cancer Medicine (2 papers)Frontiers in Oncology (2 papers)Oncotarget (2 papers)Cancer Research (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Guoping Ren
38 papers receiving 649 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 217
- Pulmonary and Respiratory Medicine 314
- Oncology 181
- Obstetrics and Gynecology 32
- Molecular Biology 250
Countries citing papers authored by Guoping Ren
This map shows the geographic impact of Guoping Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Ren more than expected).
Fields of papers citing papers by Guoping Ren
This network shows the impact of papers produced by Guoping Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Ren. The network helps show where Guoping Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoping Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 126 | |
| 2 | 2015 | 117 | |
| 3 | 2015 | 39 | |
| 4 | 2012 | 37 | |
| 5 | 2019 | 32 | |
| 6 | 2006 | 27 | |
| 7 | 2017 | 20 | |
| 8 | Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status. | 2012 | 20 |
| 9 | 2017 | 19 | |
| 10 | 2019 | 17 | |
| 11 | 2020 | 17 | |
| 12 | 2021 | 17 | |
| 13 | 2018 | 16 | |
| 14 | 2011 | 15 | |
| 15 | 2019 | 15 | |
| 16 | 2018 | 14 | |
| 17 | 2019 | 11 | |
| 18 | High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer. | 2015 | 11 |
| 19 | 2020 | 10 | |
| 20 | 2021 | 7 |
About Guoping Ren
Guoping Ren is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 40 papers that have together received 654 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), Cancer, Lipids, and Metabolism (7 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Cancer-related gene regulation (4 papers), Lung Cancer Treatments and Mutations (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Ubiquitin and proteasome pathways (3 papers) and Genetic and Kidney Cyst Diseases (2 papers). The work is most often cited by research in Cancer Research (217 citations), Pulmonary and Respiratory Medicine (314 citations), Oncology (181 citations), Obstetrics and Gynecology (32 citations) and Molecular Biology (250 citations). Guoping Ren has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yong‐Jie Lu, Xueying Mao, Daniel M. Berney, Elzbieta Stankiewicz, Jili Wang, Luis Beltrán, Jimin Shao, Xiaoyan Liu, Sakunthala C. Kudahetti and Lijun Zhu. Their work appears in journals such as BMC Cancer, Cancer Medicine, Frontiers in Oncology, Oncotarget and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.